Nonnarcotic Analgesics Archives - Page 52 of 52 - MPR

Nonnarcotic Analgesics

OFIRMEV (acetaminophen) 1000mg/100mL injection by Cadence

Ofirmev approved for management of pain and fever

The FDA has approved Ofirmev (acetaminophen, from Cadence Pharmaceuticals) injection for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics, and the reduction of fever in patients >2 years of age.

McNeil Consumer Healthcare product supply update

McNeil Consumer Healthcare announced that it does not anticipate having sources of supply for most of the products that were produced at its Fort Washington, Pennsylvania manufacturing facility before the end of 2010.

CDC issues statement and recommendations regarding prescription drug misuse

The CDC announced the 2009 National Youth Risk Behavior Survey (YRBS) found that 1 in 5 high school students have ever taken a prescription drug such as OxyContin (oxycodone, from Purdue), Percocet (oxycodone/acetaminophen, from Endo), Vicodin (hydrocodone/acetaminophen, from Abbott), Adderall (mixed salts of a single-entity amphetamine product, from Shire), Ritalin (methylphenidate, from Novartis), or Xanax (alprazolam, from Pfizer), without a prescription.

Additional warnings for Ultram and Ultracet

The FDA and PriCara have notified healthcare professionals that the Prescribing Information for Ultram (tramadol) and Ultracet (tramadol and acetaminophen) have been updated to include strengthened Warnings emphasizing the risk of suicide in patients who are addiction-prone, taking tranquilizers or antidepressant drugs, and also warns of the risk of overdosage.